Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy ERYTECH Pharma S-A stock | $5.48

Learn how to easily invest in ERYTECH Pharma S-A stock.

ERYTECH Pharma S.A is a biotechnology business based in the US. ERYTECH Pharma S-A shares (ERYP) are listed on the NASDAQ and all prices are listed in US Dollars. ERYTECH Pharma S-A employs 196 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in ERYTECH Pharma S-A

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ERYP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

ERYTECH Pharma S-A stock price (NASDAQ: ERYP)

Use our graph to track the performance of ERYP stocks over time.

ERYTECH Pharma S-A shares at a glance

Information last updated 2021-10-18.
Latest market close$5.48
52-week range$4.10 - $13.00
50-day moving average $6.07
200-day moving average $5.92
Wall St. target price$17.83
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.69

Buy ERYTECH Pharma S-A shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ERYTECH Pharma S-A stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ERYTECH Pharma S-A price performance over time

Historical closes compared with the close of $5.48 from 2021-10-22

1 week (2021-10-15) -9.57%
1 month (2021-09-23) -9.42%
3 months (2021-07-23) 15.37%
6 months (2021-04-23) -24.83%
1 year (2020-10-23) -12.04%
2 years (2019-10-21) 27.74%
3 years (2018-10-23) 7.08
5 years (2016-10-19) N/A

ERYTECH Pharma S-A financials

Revenue TTM $4.1 million
Gross profit TTM $3.7 million
Return on assets TTM -45.13%
Return on equity TTM -151.57%
Profit margin 0%
Book value $1.32
Market capitalisation $170.5 million

TTM: trailing 12 months

Shorting ERYTECH Pharma S-A shares

There are currently 15,466 ERYTECH Pharma S-A shares held short by investors – that's known as ERYTECH Pharma S-A's "short interest". This figure is 30.6% down from 22,299 last month.

There are a few different ways that this level of interest in shorting ERYTECH Pharma S-A shares can be evaluated.

ERYTECH Pharma S-A's "short interest ratio" (SIR)

ERYTECH Pharma S-A's "short interest ratio" (SIR) is the quantity of ERYTECH Pharma S-A shares currently shorted divided by the average quantity of ERYTECH Pharma S-A shares traded daily (recently around 48331.25). ERYTECH Pharma S-A's SIR currently stands at 0.32. In other words for every 100,000 ERYTECH Pharma S-A shares traded daily on the market, roughly 320 shares are currently held short.

However ERYTECH Pharma S-A's short interest can also be evaluated against the total number of ERYTECH Pharma S-A shares, or, against the total number of tradable ERYTECH Pharma S-A shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ERYTECH Pharma S-A's short interest could be expressed as 0% of the outstanding shares (for every 100,000 ERYTECH Pharma S-A shares in existence, roughly 0 shares are currently held short) or 0.0008% of the tradable shares (for every 100,000 tradable ERYTECH Pharma S-A shares, roughly 1 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ERYTECH Pharma S-A.

Find out more about how you can short ERYTECH Pharma S-A stock.

ERYTECH Pharma S-A share dividends

We're not expecting ERYTECH Pharma S-A to pay a dividend over the next 12 months.

ERYTECH Pharma S-A share price volatility

Over the last 12 months, ERYTECH Pharma S-A's shares have ranged in value from as little as $4.1 up to $13. A popular way to gauge a stock's volatility is its "beta".

ERYP.US volatility(beta: 1.92)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ERYTECH Pharma S-A's is 1.9201. This would suggest that ERYTECH Pharma S-A's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

ERYTECH Pharma S-A overview

ERYTECH Pharma S. A. , a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine-dependent cancers. It has research collaborations with the Fox Chase Cancer Center to advance the preclinical development of erymethionase for the treatment of homocystinuria; and Queen's University of Canada to advance the preclinical development of eryminase for the treatment of arginase-1-deficiency. The company was incorporated in 2004 and is headquartered in Lyon, France.

Frequently asked questions

What percentage of ERYTECH Pharma S-A is owned by institutions?
Currently 7.827% of ERYTECH Pharma S-A shares are held by institutions.
How many people work for ERYTECH Pharma S-A?
Latest data suggests 196 work at ERYTECH Pharma S-A.
When does the fiscal year end for ERYTECH Pharma S-A?
ERYTECH Pharma S-A's fiscal year ends in December.
Where is ERYTECH Pharma S-A based?
ERYTECH Pharma S-A's address is: 60 Avenue Rockefeller, Lyon, France, 69008
What is ERYTECH Pharma S-A's ISIN number?
ERYTECH Pharma S-A's international securities identification number is: US29604W1080
What is ERYTECH Pharma S-A's CUSIP number?
ERYTECH Pharma S-A's Committee on Uniform Securities Identification Procedures number is: 29604W108

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site